Shopping Cart

IBX Secures Additional Capital — Shareholders Exercise Options

IBX Secures Additional Capital — Shareholders Exercise Options

Imagion Biosystems announce that it has received $122k for the exercise of 4,080,000 listed options exercisable at 3 cents expiring on 28 April 2023.

In addition, the Company has received a request for the exercise of 2,000,000 unlisted options issued to former CFO, Brian Conn, under the Company’s ISO plan which requires employees exercise their right to vested options within 30 days of the end of their employment. The unlisted options were exercisable at 2.8 cents.

The exercise of these options has resulted in the issue of 6,080,000 fully paid ordinary shares, as outlined in the attached application for quotation (Appendix 2A).

Read Appendix 2A.


Related Articles

2023 AGM Resolution Overview

Video Transcript: Robert Proulx, Imagion Biosystems’ President & CEO: [00:00:00] On April 24th, we sent out the notice of meeting for our annual general meeting

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.